Strategy

Sales & Marketing

Behavioural science in biopharma: Convincing backers and phy...

Novel therapies, often with expensive price tags and finite patient populations, require strategic new positioning if they are to have maximum positive impact.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

Innovation as Strategy webinar: Enabling life sciences of the future

Innovation as Strategy: Enabling life sciences of the future

Explore “Innovation as Strategy” framework, providing a guide for employing innovative strategies in life sciences.

R&D

Big pharma places big bets on antibody-drug conjugates

Antibody-drug conjugates have emerged as one of the most popular treatment modalities for investment in recent years.

Digital

6 critical success factors for a rapid first commercial laun...

The success of any drug launch begins long before a regulatory agency gives the product the green light.

News

Sanofi says new drugs can add €10bn to sales by 2030

Sanofi said this morning that its pipeline includes 12 potential blockbuster drugs that could generate more than €10 billion ($11 billion) in annual sales by the end of th

Market Access

A strategic approach to local affiliates in the global era

While global harmonisation remains the holy grail, the reality is that pharmaceutical companies still face significant challenges navigating regulatory differences.